Author:
Rigaud Jérôme,Leger Alexandra,Devilder Marie-Claire,Bouchot Olivier,Bonneville Marc,Scotet Emmanuel
Funder
Ligue Nationale contre le cancer
CHU de Nantes
Reference19 articles.
1. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006
2. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer;Malmstrom;Eur Urol,2009
3. Recommandations en Onco-Urologie 2010: Tumeurs urotheliales;Pfister;Prog Urol,2010
4. Intravesical bacillus Calmette-Guérin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002
5. Maintenance bacillus Calmette-Guérin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study;Lamm;J Urol,2000
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献